Advertisement

 

 

Availability and Patterns of Intravesical BCG Instillations.

Availability and Patterns of Intravesical BCG Instillations.
Author Information (click to view)

Poletajew SA, Majek A, Magusiak P, Ledzikowska K, Dybowski B, Radziszewski P,


Poletajew SA, Majek A, Magusiak P, Ledzikowska K, Dybowski B, Radziszewski P, (click to view)

Poletajew SA, Majek A, Magusiak P, Ledzikowska K, Dybowski B, Radziszewski P,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Urology journal 2017 11 0414(6) 5068-5070 doi 10.22037/uj.v14i6.3781
Abstract
PURPOSE
Intravesical BCG instillations improve recurrence free survival in patients with non-muscle-invasive bladder cancer (NMIBC).

METHODS
This is a national survey study, covering 223 urological centres, aimed at reliable identification of BCG availability and implemented treatment patterns.

RESULTS
Response rate was 93.7%. BCG was used in 56.5% of urological departments. Another 22.7% referred patients to other hospitals for instillations, while 20.8% did not recommend BCG at all. The most common indications for BCG instillations were as follows: T1 tumours (88.5%), carcinoma in situ (83.6%) and high grade tumours (73.8%). Maintenance therapy was routinely abandoned in 16.4% of centres or was scheduled for <1 year, 1 year, 3 years and 1-3 years in 6.6%, 19.7%, 21.3% and 31.2% of centres, respectively. Continuation of BCGdespite treatment failure in carcinoma in situ cases was considered in 21.3% of departments. CONCLUSION
Our findings indicate that BCG is underused, while patterns of maintenance and follow-up are suboptimal.

Submit a Comment

Your email address will not be published. Required fields are marked *

seventeen − fourteen =

[ HIDE/SHOW ]